Release of cytochrome c into the cytosol

Where it participates (unsigned role)

1. Leflunomide given 4 hours after a hepatotoxic dose of acetaminophen afforded significant protection from liver necrosis by serum alanine aminotransferase and histopathology at 8 and 24 hours, and the mechanism was not inhibition of cytochrome-P450-catalysed bioactivation or suppression of innate immunity but inhibition of acetaminophen-induced phosphorylation of c-Jun N-terminal protein kinase, preventing downstream Bcl-2 and Bcl-XL inactivation and protecting from mitochondrial permeabilization and cytochrome c release, while also preventing induction of inducible nitric oxide synthase and formation of peroxynitrite; protection was still obtained when given 8 hours after the dose.

   c-Jun N-terminal kinase → Hepatic necrosis source_derived_draftungraded
   Experimental context and source evidence

   availability_state

   biomarker_context Imported condition classification; unverified.

   evidence_span

   {"source_cache": "artifacts/paracetamol-research/17366662.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c7eb70728aa75fa3ac54f70703ce08d7a540b3a2a7da7e4797f27a6b1312dbb", "start_char": 0, "end_char": 1791, "text_sha256": "7c7eb70728aa75fa3ac54f70703ce08d7a540b3a2a7da7e4797f27a6b1312dbb"}

   experimental_model

   Male C57BL/6 mice given a hepatotoxic dose followed by leflunomide at 4 or 8 hours

   exposure

   750 milligrams per kilogram acetaminophen intraperitoneally, rescued with 30 milligrams per kilogram leflunomide

   limitations

   A rescue given hours after the dose, which separates the injury pathway from the bioactivation step. A mouse model at a dose far above therapeutic.

   nutrient_topic

   Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. · Paracetamol

   organism

   Mouse

   plain_language

   The damage is done by a signalling kinase hours later, not by the chemistry of the metabolite alone, which is why a late rescue works.

   primary_references

   [apap-p17366662] Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. (2007). https://pubmed.ncbi.nlm.nih.gov/17366662/ DOI: 10.1002/hep.21475

   tissue_or_cell_type

   Liver

   trigger_kind

   biomarker_context Imported condition classification; unverified.

   Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22) · lines 415–426

   AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Male C57BL/6 mice given a hepatotoxic dose followed by leflunomide at 4 or 8 hours · source_derived_draft · unverified_draft

   ### apap-jnk-not-bioactivation Leflunomide given 4 hours after a hepatotoxic dose of acetaminophen afforded significant protection from liver necrosis by serum alanine aminotransferase and histopathology at 8 and 24 hours, and the mechanism was not inhibition of cytochrome-P450-catalysed bioactivation or suppression of innate immunity but inhibition of acetaminophen-induced phosphorylation of c-Jun N-terminal protein kinase, preventing downstream Bcl-2 and Bcl-XL inactivation and protecting from mitochondrial permeabilization and cytochrome c release, while also preventing induction of inducible nitric oxide synthase and formation of peroxynitrite; protection was still obtained when given 8 hours after the dose. Condition category: biomarker_context nutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. plain_language: The damage is done by a signalling kinase hours later, not by the chemistry of the metabolite alone, which is why a late rescue works. organism: Mouse tissue_or_cell_type: Liver experimental_model: Male C57BL/6 mice given a hepatotoxic dose followed by leflunomide at 4 or 8 hours limitations: A rescue given hours after the dose, which separates the injury pathway from the bioactivation step. A mouse model at a dose far above therapeutic. exposure: 750 milligrams per kilogram acetaminophen intraperitoneally, rescued with 30 milligrams per kilogram leflunomide evidence_span: {"source_cache": "artifacts/paracetamol-research/17366662.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "7c7eb70728aa75fa3ac54f70703ce08d7a540b3a2a7da7e4797f27a6b1312dbb", "start_char": 0, "end_char": 1791, "text_sha256": "7c7eb70728aa75fa3ac54f70703ce08d7a540b3a2a7da7e4797f27a6b1312dbb"} [apap-p17366662] Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. (2007). https://pubmed.ncbi.nlm.nih.gov/17366662/ DOI: 10.1002/hep.21475

   Complete structured claim and evidence

2. Treatment of U251 glioma cells with capsaicin and dihydrocapsaicin resulted in a dose- and time-dependent inhibition of cell viability and induction of apoptosis, whereas few effects were observed on the viability of L929 normal murine fibroblast cells, and the apoptosis was associated with generation of reactive oxygen species, increased calcium concentrations, mitochondrial depolarization, release of cytochrome c into the cytosol and activation of caspase-9 and caspase-3, with anti-tumour effects confirmed in a murine tumour xenograft model.

   Dihydrocapsaicin → Viability of U251 human glioma cells source_derived_draftungraded
   Experimental context and source evidence

   evidence_span

   {"source_cache": "artifacts/dihydrocapsaicin-research/27748914.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ffc172fb64714099772462ba33304b69637efac75f1f218f2032e26bbc32dc90", "start_char": 0, "end_char": 1610, "text_sha256": "ffc172fb64714099772462ba33304b69637efac75f1f218f2032e26bbc32dc90"}

   experimental_model

   U251 human glioma cells with flow cytometry, transmission electron microscopy and a murine xenograft model

   exposure

   Capsaicin and dihydrocapsaicin applied across doses and times, with L929 normal fibroblasts as a selectivity control

   limitations

   Includes a normal-cell control and an in vivo arm. Cell-line concentrations are not stated in the abstract and are not assumed here.

   nutrient_topic

   Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin. · Dihydrocapsaicin

   organism

   Human cells and mouse

   plain_language

   It kills glioma cells through the mitochondria while largely sparing normal cells.

   primary_references

   [dhc-p27748914] Capsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca2+‑mediated mitochondrial pathway. (2016). https://pubmed.ncbi.nlm.nih.gov/27748914/ DOI: 10.3892/mmr.2016.5784

   tissue_or_cell_type

   Glioma cells

   Dihydrocapsaicin: the second capsaicinoid, the hypothermia it is used to induce, what the gut and liver do to it, and what it does without TRPV1 (2026-09-21) · lines 712–723

   AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · U251 human glioma cells with flow cytometry, transmission electron microscopy and a murine xenograft model · source_derived_draft · unverified_draft

   ### dhc-glioma-apoptosis Treatment of U251 glioma cells with capsaicin and dihydrocapsaicin resulted in a dose- and time-dependent inhibition of cell viability and induction of apoptosis, whereas few effects were observed on the viability of L929 normal murine fibroblast cells, and the apoptosis was associated with generation of reactive oxygen species, increased calcium concentrations, mitochondrial depolarization, release of cytochrome c into the cytosol and activation of caspase-9 and caspase-3, with anti-tumour effects confirmed in a murine tumour xenograft model. Condition category: normal nutrient_topic: Dihydrocapsaicin research collection; topical membership is not evidence of a direct clinical effect, and dihydrocapsaicin is recorded separately from capsaicin. plain_language: It kills glioma cells through the mitochondria while largely sparing normal cells. organism: Human cells and mouse tissue_or_cell_type: Glioma cells experimental_model: U251 human glioma cells with flow cytometry, transmission electron microscopy and a murine xenograft model limitations: Includes a normal-cell control and an in vivo arm. Cell-line concentrations are not stated in the abstract and are not assumed here. exposure: Capsaicin and dihydrocapsaicin applied across doses and times, with L929 normal fibroblasts as a selectivity control evidence_span: {"source_cache": "artifacts/dihydrocapsaicin-research/27748914.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ffc172fb64714099772462ba33304b69637efac75f1f218f2032e26bbc32dc90", "start_char": 0, "end_char": 1610, "text_sha256": "ffc172fb64714099772462ba33304b69637efac75f1f218f2032e26bbc32dc90"} [dhc-p27748914] Capsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca2+‑mediated mitochondrial pathway. (2016). https://pubmed.ncbi.nlm.nih.gov/27748914/ DOI: 10.3892/mmr.2016.5784

   Complete structured claim and evidence